The Prevalence Of Hyperhomocysteinemia And Its Correlation With Conventional Risk Factors In Young Patients With Myocardial Infarction
The Prevalence Of Hyperhomocysteinemia And Its Correlation
DOI:
https://doi.org/10.70284/njirm.v4i1.2131Keywords:
Acute myocardial infarction, young adults, homocysteine, conventional risk factorsAbstract
Background: Ischemic heart disease is a leading cause of death throughout the world. Indians are more prone to premature coronary artery disease. About 20% patients with CAD have no identifiable risk factors. Thus the importance of homocysteine as a risk factor for CAD in Indian patients needs to be recognized. Objective: The present study was designed to find out association between the plasma homocysteine and traditional risk factors in young acute myocardial infarction patients. Materials And Methods: The study included 50 male patients of less than 40 years old, who were fulfilling the WHO criteria for acute myocardial Infarction presenting within 48 hours. Plasma homocysteine levels were studied in addition to the traditional risk factors. RESULTS: The mean age of the patients was 34.1 ±4.2years. The mean homocysteine level was 23.58 ±6.2 μmol/L. The prevalence of hyperhomocysteinemia was 70% in the study subjects. Plasma homocysteine levels were significantly increased in patients with smoking. (p≤0.001),alcoholism(p≤0.003) and dyslipidemia(p≤0.006) . Elevation of homocysteine levels in patients with Diabetes mellitus, Hypertension and family history of CAD (coronary artery disease) was not significant. Conclusion: Our results showed that homocysteine levels are elevated in young patients with AMI. In the present study significantly higher level of homocysteine was found in smokers, patients with alcoholism and dyslipidemia. However, there was no significant elevation was found in Diabetes mellitus, Hypertension and family history of CAD. Plasma homocysteine has emerged as a significant independent risk factor for young MI patients. Therefore, plasma homocysteine should be evaluated in all young patients with myocardial infarction especially in the absence of traditional risk factors.
References
2. Mukherjee D, Hsu A, Moliterno DJ, et al. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < 40 years old. Am J Cardiology 2003; 92: 1465-7.
3. Kannel WB, Abbott RO, Incidence and prognosis of unrecognized myocardial infarction. New Engl J Med 1984; 311:1144-1147.
4. Enas EA, Senthilkumar A. Coronary Artery Disease in Asian Indians: An Update and Review. Int J Cardiology 2002; 1(2):1-34.
5. Mammi MV, Pavithran K, Rahiman PA, Pisharody R, Sugathan K. Acute myocardial infarction in North Kerala- a 20-year hospital based study. Ind Heart J 1991; 43: 93-96.
6. Negus BH, Willard JE, Glamann DB, Landau C, Snyder RW2nd, Hillis LD, et al. Coronary anatomy and prognosis of young asymptomatic survivors of myocar-dial infarction. Am J Med 1994; 96; 354-358.
7. Murray CJL, Lopez AD. Global comparative assessments in the health sector. Geneva, Switzerland, WHO 1994.
8. Smith SC Jr. Current and future directions of cardio-vascular risk prediction. Am J Cardiol. 2006; 97: 28A-32A9. Rhoads GG, Blackweld WC, Stemmerman GN, et al. Coronary risk factors and autopsy findings. Lab Invest 1978; 38; 304-11.
10. Kaul U, Manchanda SC, Bhatia ML. Myocardial infarction in young Indian patients, risk factors and angiographic profile. Am Heart J 1986; 71:112-5.
11. Ueland PM. Homocysteine species as components of plasma redox thiol status.Clin Chem; 1995:340-2.
12. Welch GN, Loscalzo J. Homocysteine and atherothrombosis.
13. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma a quantitative assessment risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-1057.
14. Murphy-chutorian D, Alderman EL. The case that hyperhomocysteinemia is a risk factor for coronary artety disease. Am J Cardiol 1994;73:705-6.
15. Clarke R, Daly L, Robinson K, Naughten E, Cahlene S, Fowler B, et al. Hyperhomocysteinemia is an independent risk factor for coronary artery disease. N Engl J Med; 2324:1149-55.
16. Puri A, Gupta OK, Dwivedi RN, Bharadwaj RPS, Na-rain VS, Singh S. Homocysteine and lipid levels in young patients with coronary artery disease. JAPI 2003; 51: 681-685.
17. Kumar Y, Das R, Garewal G. High prevalence of hyperhomocysteinemia in young population of North India – A potential risk factor for coronary artery disease? Thrombosis Research 2009; 123:800-802.
18. Mohammad Masoomi, Abbas B, Masoud M, Alireza N. Palsma Homocycteine concentrations in young patients with acute myocardial infarction. ARYA Atherosclerosis Journal 2007, 2(4); 193-196.
19. Conner EL, Cohn BA, Wingard DL. Why diabetes mellitus is a strong risk factor of fatal ischemic heart disease. J Am Med Assoc 1991; 265; 627-9.
20. Pearson TA, McBride PE, Miller NH, Smith SC. 27th Bathesda conference: Matching the intensity of risk factor management. In CAD. J. Am Coll Cardiol 1996; 27:1039-47.
21. Kumar A, Khan S A, Parvez A, Zaheer M S, Rabbani M U, Zafar L.; The prevalence of hyperhomocysteinemia and its correlation with conventional risk factors in young patients with myocardial infarction in a tertiary care centre of India; Biomedical Research, 2011; 22: (2), 224-228.
22. Abraham R, Joseph John M, Calton R, Dhanoa J.; Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration; Indian Journal of Clinical Biochemistry, 2006, 21 (1) 95-100.
23. Angeline T, Rita Mary Aruna, Ramadevi K, Mohan G, and Nirmala Jeyaraj; Homocysteine Status and Acute Myocardial Infarction among Tamilians; Indian Journal of Clinical Biochemistry, 2005; 20(1):18-20.
24. Rao BH, Govindaraju V, Manjunath CN. Risk prediction– homocysteine in coronary heart disease. Indian Journal of Clinical Biochemistry 2007; 22: 18-21.
25. Lo Rosa JC. The cholesterol facts. A joint statement by the Am Heart Assoc and NHLBI. Circulation 1990; 81:1721-33.
26. Boushey CJ, Bareford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of in-creasing folic acid intake. J Am Med Asso 1995; 274: 1049-1057
27. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstorm LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease : the European Concerted Action Project. J Am Med Assoc 1997; 277: 1775-1781.
28. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. Plasma homocysteine and risk of CAD in UK Indian Asian and European men. Lancet 2000; 355: 523-527.
29. Tambe AB. Homocysteine and atherosclerotic vascular disease. Cardiology Today 2000; 4: 269-71.
